Phase 3 study for people with Myeloma

Not yet recruiting Phase 3

Sources: ClinicalTrials.gov Checked: 11 October 2026 Not medical advice

This trial at a glance

Status Not yet recruiting
Phase Phase 3
Sponsor AbbVie
Registry number NCT07728188
Started 30 November 2026 Today 16 October 2026 Estimated completion 1 February 2033

Where this trial is running

Trial sites and the status recorded for each
SiteCityState or countryStatus at this site
Wollongong Hospital. /ID# 282694 Wollongong NSW Status not stated
Pindara Private Hospital /ID# 283010 Benowa QLD Status not stated
Icon Cancer Care - South Brisbane /ID# 282965 South Brisbane QLD Status not stated
Peter MacCallum Cancer Centre. /ID# 282692 Melbourne VIC Status not stated
Epworth Hospital - Richmond /ID# 281877 Richmond VIC Status not stated
Fiona Stanley Hospital /ID# 281879 Murdoch WA Status not stated
Sir Charles Gairdner Hospital /ID# 281881 Nedlands WA Status not stated

voxsanity.com.au · trial sites from public registries · registry record synced 11 October 2026 · not medical advice

Who can join

Age 18 Years and over
Sex Anyone, regardless of sex
Healthy volunteers Not accepted
Enrolment target 520

The official eligibility criteria

Registry text, reproduced exactly. These are the words the trial's sponsor published on ClinicalTrials.gov. They have not been edited, shortened or rewritten, and they are written for researchers rather than for patients.

Inclusion Criteria:

* Diagnosis of relapsed or refractory (RR) multiple myeloma (MM).

* Prior treatment with at least one and no more than three prior lines of therapy, including lenalidomide.

* Adequate organ function and performance status

Exclusion Criteria:

* Prior B-cell maturation antigen (BCMA) directed T-cell engager therapy (bispecific or trispecific)

* Known central nervous system involvement of MM

* Known history of other active malignancies within the past 3 years (with specific exceptions)

* Clinically significant conditions (renal, neurologic, psychiatric, endocrine, metabolic, immunologic, cardiovascular, pulmonary, or hepatic disease within the last 6 months)

Dates on the record

Started 30 November 2026
Estimated completion 1 February 2033
Registry last updated 27 July 2026
Checked by Voxsanity 11 October 2026

Results, publications and the official record

Sources and dates

  • ClinicalTrials.gov – the record this page reformats
  • ClinicalTrials.gov processing date: 27 July 2026.
  • This page last checked by Voxsanity: 11 October 2026.

Voxsanity reformats data from public registries into this layout. It does not edit, interpret or add to what the registry published.

Not medical advice.

Individual trial records are refreshed on a rolling basis rather than all at once, so a record may be up to several weeks old. Each trial page and trial card shows the date its own record was last synced. Where a record has lagged, its status, sites and enrolment can differ from the current registry state in either direction, so check the registry link on the trial page before acting on them.

Letter for your doctor

A one-page summary of this trial to print or email to your GP. It carries the registry's own record of the trial and its eligibility criteria, and nothing Voxsanity has written about whether it suits you.